Clinical Trial Update: Tailored Treatment of H. Pylori Infection Based Polymorphisms of CYP2C19 and 23S rRNA of H. Pylori [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating a tailored treatment strategy for Helicobacter pylori infection based on CYP2C19 and 23S rRNA polymorphisms.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duodenal Ulcer
• Gastric Ulcer
• Gastritis
• Helicobacter Pylori Infection

Snippet

Sponsor: Hamamatsu University | Conditions: Helicobacter Infections, Gastritis | Phase 3 | Status: UNKNOWN